Parkinson's Disease Biomarker
AssigneeUniversity of Dundee
InventorsDario Alessi, Muratul Muqit
Life of this patent
Estimating the term…
Abstract
The present invention relates to a biomarker for Parkinson's disease. The biomarker and products associated with the biomarker may be used to assist diagnosis or to assess onset and/or development of Parkinson's disease. The invention also relates to use of the biomarker in clinical screening, assessment of prognosis, evaluation of drug treatments, drug screening or drug development in the field of Parkinson's disease and Parkinson's disease related disorders.
Claims16
1-10. (canceled)
An in vitro method of diagnosing Parkinson's disease, monitoring of progression of Parkinson's disease, assessing response to therapy and/or screening drugs for treating Parkinson's disease, the method comprising detecting phosphorylation of amino acid residues of the parkin and PINK1 protein.
A molecule that specifically binds to phosphorylated or unphosphorylated Ser65 of parkin or Thr257 of PINK1 or region comprising said residue(s).
A kit for diagnosing Parkinson's disease, monitoring progression of the disease and/or assessing response to therapy, the kit comprising at least one marker specific reagent that specifically binds to phosphorylated or unphosphorylated Ser65 of parkin or Thr257 of PINK1 or region comprising said residue(s).
Dependencies are inferred from the claim text.